AGIO
Price
$32.27
Change
-$0.05 (-0.15%)
Updated
Mar 1, 6:59 PM EST
61 days until earnings call
VCYT
Price
$24.00
Change
+$0.45 (+1.91%)
Updated
Mar 1, 6:59 PM EST
59 days until earnings call
Ad is loading...

Analysis and predictions AGIO vs VCYT

Header iconAGIO vs VCYT Comparison
Open Charts AGIO vs VCYTBanner chart's image
Agios Pharmaceuticals
Price$32.27
Change-$0.05 (-0.15%)
Volume$479.25K
CapitalizationN/A
Veracyte
Price$24.00
Change+$0.45 (+1.91%)
Volume$332.56K
CapitalizationN/A
View a ticker or compare two or three
AGIO vs VCYT Comparison Chart

Loading...

AGIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AGIO vs. VCYT commentary
Mar 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and VCYT is a Hold.

COMPARISON
Comparison
Mar 02, 2024
Stock price -- (AGIO: $32.27 vs. VCYT: $24.00)
Brand notoriety: AGIO and VCYT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 54% vs. VCYT: 62%
Market capitalization -- AGIO: $1.81B vs. VCYT: $1.72B
AGIO [@Biotechnology] is valued at $1.81B. VCYT’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $530.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 1 green, 4 red.
According to our system of comparison, both AGIO and VCYT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 6 TA indicator(s) are bullish while VCYT’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 6 bullish, 4 bearish.
  • VCYT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than VCYT.

Price Growth

AGIO (@Biotechnology) experienced а -2.18% price change this week, while VCYT (@Biotechnology) price change was +8.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was +20.20%, and the average quarterly price growth was +48.09%.

Reported Earning Dates

AGIO is expected to report earnings on May 02, 2024.

VCYT is expected to report earnings on Apr 30, 2024.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AGIO with price predictions.
OPEN
A.I.dvisor published
a Summary for VCYT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AGIO($1.81B) has a higher market cap than VCYT($1.72B). AGIO YTD gains are higher at: 44.903 vs. VCYT (-12.759). VCYT has higher annual earnings (EBITDA): -22.16M vs. AGIO (-384.86M). AGIO has more cash in the bank: 777M vs. VCYT (202M). VCYT has less debt than AGIO: VCYT (13.7M) vs AGIO (72M). VCYT has higher revenues than AGIO: VCYT (343M) vs AGIO (26.8M).
AGIOVCYTAGIO / VCYT
Capitalization1.81B1.72B105%
EBITDA-384.86M-22.16M1,737%
Gain YTD44.903-12.759-352%
P/E RatioN/AN/A-
Revenue26.8M343M8%
Total Cash777M202M385%
Total Debt72M13.7M526%
FUNDAMENTALS RATINGS
AGIO vs VCYT: Fundamental Ratings
AGIO
VCYT
OUTLOOK RATING
1..100
4015
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
9691
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (26) in the Biotechnology industry is in the same range as AGIO (48). This means that VCYT’s stock grew similarly to AGIO’s over the last 12 months.

VCYT's Profit vs Risk Rating (86) in the Biotechnology industry is in the same range as AGIO (100). This means that VCYT’s stock grew similarly to AGIO’s over the last 12 months.

VCYT's SMR Rating (91) in the Biotechnology industry is in the same range as AGIO (96). This means that VCYT’s stock grew similarly to AGIO’s over the last 12 months.

VCYT's Price Growth Rating (50) in the Biotechnology industry is in the same range as AGIO (50). This means that VCYT’s stock grew similarly to AGIO’s over the last 12 months.

VCYT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AGIO (100). This means that VCYT’s stock grew similarly to AGIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIOVCYT
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 5 days ago
72%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
AGIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VCYTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIVOX10.13N/A
N/A
Fidelity Advisor International Value C
TAREX21.48N/A
N/A
Third Avenue Real Estate Value Instl
FSPSX48.47N/A
N/A
Fidelity International Index
COVUX9.99N/A
N/A
Columbia Overseas Value R
PLABX36.69N/A
N/A
Plumb Balanced A

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+1.91%
NTLA - VCYT
70%
Closely correlated
+1.68%
SRNEQ - VCYT
62%
Loosely correlated
N/A
VCEL - VCYT
60%
Loosely correlated
-2.12%
DNA - VCYT
59%
Loosely correlated
-15.13%
AXON - VCYT
58%
Loosely correlated
+2.26%
More